Stockscreener 앱 받기
0.72
1.41%
0.01
전일 마감가:
$0.71
열려 있는:
$0.95
하루 거래량:
19,134
Relative Volume:
0.18
시가총액:
$5.12M
수익:
-
순이익/손실:
$-50.18M
주가수익비율:
-0.0873
EPS:
-8.2506
순현금흐름:
$-45.31M
1주 성능:
-18.18%
1개월 성능:
-64.71%
6개월 성능:
-86.93%
1년 성능:
-89.02%
1일 변동 폭
$0.71
$0.95
1주일 범위
$0.70
$1.00
52주 변동 폭
$0.35
$13.75
바이케리어스 서지컬 Stock (RBOT) Company Profile
명칭
Vicarious Surgical Inc
전화
(617) 868-1700
주소
78 FOURTH AVENUE, WALTHAM
Compare RBOT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
0.72 | 13.67M | 0 | -50.18M | -45.31M | -8.2506 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
바이케리어스 서지컬 Stock (RBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 개시 | Credit Suisse | Outperform |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-11-05 | 개시 | Canaccord Genuity | Buy |
| 2021-10-18 | 개시 | BTIG Research | Buy |
| 2021-10-07 | 개시 | Piper Sandler | Overweight |
모두보기
바이케리어스 서지컬 주식(RBOT)의 최신 뉴스
Vicarious Surgical Completes Integrated Benchtop Testing of Surgical Instruments - National Today
Vicarious Surgical completes testing of surgical instrument suite By Investing.com - in.investing.com
Three robotic surgery tools clear first full-system test for hernia repair - stocktitan.net
If You Invested $1,000 in Vicarious Surgical Inc (RBOT) - stocktitan.net
Vicarious Surgical stock upgrades to OTCQB market By Investing.com - Investing.com Australia
Vicarious Surgical stock upgrades to OTCQB market - Investing.com
Vicarious Surgical begins quotation on the OTCQB as part of strategic path toward potential Nasdaq listing - marketscreener.com
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing - The Manila Times
Vicarious Surgical moves to OTCQB as it works toward a Nasdaq listing - stocktitan.net
Buyback Watch: Will Vicarious Surgical Inc outperform tech stocks2026 Buyback Activity & Daily Entry Point Alerts - baoquankhu1.vn
Reverse split plan at Vicarious Surgical (RBOT) after NYSE delisting - stocktitan.net
Vicarious Surgical (RBOT) voluntarily withdraws Class A stock from NYSE listing - stocktitan.net
Growth Value: Can Vicarious Surgical Inc beat the S P 5002026 Retail & Daily Profit Maximizing Tips - baoquankhu1.vn
Aug Technicals: Can Vicarious Surgical Inc beat the S P 500Market Performance Recap & Reliable Trade Execution Plans - baoquankhu1.vn
Growth Recap: What is Vicarious Surgical Incs valuation compared to sector2026 Levels & Risk Controlled Swing Alerts - baoquankhu1.vn
Vicarious Surgical sees FY2026 cash burn of $35 million - msn.com
Vicarious Surgical applies for Nasdaq listing - MedTech Dive
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing - Ortho Spine News
Vicarious Surgical announces strategic plan to pursue Nasdaq listing - marketscreener.com
Vicarious Surgical Announces Strategic Plan To Pursue Nasdaq Listing - TradingView
Reverse split proposal aims to relist Class A shares (RBOT) on Nasdaq - Stock Titan
ETFs Investing in Vicarious Surgical, Inc. Class A Stocks - TradingView
Total revenue of Vicarious Surgical Inc. – OTC:RBOT - TradingView
After tax other income/expense of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Non-controlling/minority interest of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Diluted earnings per share (diluted EPS) of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Discontinued operations of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Operating expenses (excl. COGS) of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Preferred dividends of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Dilution adjustment of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Diluted shares outstanding of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Total operating expenses of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Vicarious Surgical Inc. Income Statement – OTC:RBOT - TradingView
The Technical Signals Behind (RBOT) That Institutions Follow - Stock Traders Daily
Vicarious Surgical System: Next-Generation Single-Port Robotic Surgery Platform, FDA Pathway, and Market Strategy Overview - Minichart
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results - Ortho Spine News
Vicarious Surgical Delisted to OTC as Losses Narrow - TipRanks
NYSE delists Vicarious Surgical (RBOT); 2025 net loss totals $50M - Stock Titan
Vicarious Surgical projects cash burn drop from $45.1M to $19M - Stock Titan
Aug Weekly: Is Vicarious Surgical Inc Equity Warrant stock undervalued right nowEarnings Risk Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
Vicarious Surgical Inc.(OTCPK: RBOT) dropped from S&P TMI Index - marketscreener.com
Will Vicarious Surgical Inc. Equity Warrant stock deliver strong dividend growthPortfolio Value Summary & Free Accurate Trade Setup Notifications - Naître et grandir
Weekly Earnings: What is Vicarious Surgical Incs valuation compared to sectorProduct Launch & Community Supported Trade Ideas - baoquankhu1.vn
Wall Street Recap: Can Vicarious Surgical Inc be the next market leaderPortfolio Gains Summary & Capital Protection Trade Alerts - baoquankhu1.vn
Vicarious Surgical Implements Executive Salary Reductions, Maintains Incentives - TipRanks
Stock Market Recap: Will Vicarious Surgical Inc Equity Warrant outperform its industry peersEarnings Risk Report & Weekly Top Gainers Trade List - baoquankhu1.vn
Levels Update: Can Vicarious Surgical Inc be recession proofDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
EBITDA margin % of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Vicarious Surgical Inc. Balance Sheet – OTC:RBOT - TradingView
CapEx per share of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Vicarious Surgical, Inc. Class A Financial Disclosures & SEC Filings - TradingView
바이케리어스 서지컬 (RBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.03%
자본화:
|
볼륨(24시간):